First Trust Direct Indexing’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-6,942
Closed -$4.29M – 837
2024
Q3
$4.29M Buy
6,942
+763
+12% +$452K 0.23% 79
2024
Q2
$3.42M Buy
6,179
+1,198
+24% +$686K 0.21% 89
2024
Q1
$2.9M Buy
4,981
+945
+23% +$530K 0.22% 89
2023
Q4
$2.14M Buy
4,036
+1,187
+42% +$575K 0.19% 111
2023
Q3
$1.44M Buy
2,849
+472
+20% +$252K 0.16% 134
2023
Q2
$1.24M Sell
2,377
-183
-7% -$98.8K 0.14% 165
2023
Q1
$1.48M Buy
2,560
+187
+8% +$105K 0.18% 138
2022
Q4
$1.31M Sell
2,373
-50
-2% -$26.5K 0.17% 142
2022
Q3
$1.23M Buy
2,423
+4
+0.2% +$2.24K 0.18% 136
2022
Q2
$1.31M Buy
2,419
+309
+15% +$170K 0.18% 139
2022
Q1
$1.25M Buy
2,110
+178
+9% +$102K 0.15% 166
2021
Q4
$1.29M Hold
1,932
– – 0.17% 145
2021
Q3
$1.1M Buy
1,932
+110
+6% +$60.4K 0.16% 154
2021
Q2
$919K Sell
1,822
-371
-17% -$175K 0.14% 188
2021
Q1
$1M Buy
2,193
+255
+13% +$122K 0.27% 96
2020
Q4
$903K Buy
+1,938
New +$909K 0.24% 96

Other funds holding TMO

First Trust Direct Indexing's TMO Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 6,942 shares — an estimated $4.29M sold.

First Trust Direct Indexing first reported a position in TMO in Q4 2020 and held it in 16 quarters. The position peaked at $4.29M in Q3 2024. 2,628 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 6,942 Thermo Fisher Scientific shares in Q4 2024, an estimated $4.29M.
  • First Trust Direct Indexing first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Thermo Fisher Scientific position peaked at $4.29M in Q3 2024.
  • 2,628 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.